Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced that safety and efficacy ...

It warns: "You need to tell DVLA about some medical conditions as they can affect your driving. You can be fined up to £1,000 ...

Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal ...

Previous research has shown that voretigene neparvovec administered subretinally early in childhood for RPE65-mediated ...

However if you have a medical condition that affects your driving but don't voluntarily give up your licence, you must inform the DVLA, which will decide if you can continue holding a driving licence.

Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...

The US Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to Beacon ...

The companies will work together by using the codon-optimized BBS1 AAV9 vector to minimize the vision loss caused by the ...

To avoid disaster, the Government has limits for legal and illegal drugs, so ask your doctor if you’re unsure. But it’s not just prescription drugs that can see you banned from the steering wheel - ...

Muscular dystrophy (MD) represents a group of inherited muscle disorders that primarily cause muscle weakness and muscle wasting, though some types of the disease also present with other ...

The companies will focus on advancing AXV-101, with which they hope to treat retinal dystrophy by targeting mutations in the BBS1 gene.

Viralgen and Axovia Therapeutics are set to form a partnership to progress the development and manufacturing of an adeno-associated virus vector serotype 9 (AAV9)-based gene therapy for retinal ...